Harish Shantharam
Net worth: 148 200 $ as of 2026-05-30
Net worth: 148 200 $ as of 2026-05-30
Harish Shantharam currently works at ALX Oncology Holdings, Inc., as Chief Financial Officer from 2025.
Mr. Shantharam also formerly worked at CymaBay Therapeutics, Inc., as Chief Financial & Accounting Officer in 2024, Gilead Sciences, Inc., as Vice President-Global Commercial Finance from 2011 to 2022, and Amgen, Inc., as Head-Business Development from 2004 to 2011.
Mr. Shantharam received his graduate degree from The University of Texas at Arlington and Masters Business Admin degree from UCLA Anderson School of Management.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-03-30 | 78,000 ( 0.06% ) | 148 200 $ | 2026-05-30 |
| Companies | Position | Start |
|---|---|---|
| ALX ONCOLOGY HOLDINGS INC. | Director of Finance/CFO | 2025-01-20 |
| Companies | Position | End |
|---|---|---|
| CYMABAY THERAPEUTICS, INC. | Director of Finance/CFO | 2024-03-21 |
| GILEAD SCIENCES, INC. | Corporate Officer/Principal | 2022-04-30 |
| AMGEN INC. | Corporate Officer/Principal | 2011-10-31 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 6 |
|---|---|
Amgen, Inc.
Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Gilead Sciences, Inc.
Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
CymaBay Therapeutics, Inc.
CymaBay Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for people with life-threatening diseases | Health Technology |
The University of Texas at Arlington
The University of Texas at Arlington Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
UCLA Anderson School of Management
UCLA Anderson School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ALX Oncology Holdings, Inc.
ALX Oncology Holdings, Inc. BiotechnologyHealth Technology Operates as clinical stage immuno-oncology company, which develops therapies for cancer | Health Technology |
Select your edition
All financial news and data tailored to specific country editions